Papers

1

Total Citations

6

H-Index

1

About

Dr. Bharti Gajera is a pharmaceutical scientist whose work bridges automated laboratory technology and drug discovery. Her primary research focuses on developing high-throughput screening platforms and assay optimization for lead compound characterization. Her most cited work, "Development of a Platform to Enable Fully Automated Cross-Titration Experiments" (2016, 6 citations), introduces a novel automated system that streamlines the triage of hits from high-throughput screening campaigns. This platform enables researchers to efficiently test compounds at multiple concentrations to determine potency and maximal effect, while also facilitating complex follow-up experiments like agonist shift studies. By automating these labor-intensive processes, Dr. Gajera's contributions help accelerate the critical transition from initial hit identification to lead optimization in drug development pipelines. Her work represents an important advance in laboratory automation, reducing manual error and increasing throughput in pharmaceutical research. Though her citation count is modest, the practical applications of her platform design continue to support medicinal chemistry teams seeking more efficient ways to characterize promising drug candidates.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Development of a Platform to Enable Fully Automated Cross-Titration Experiments
6 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago